Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2007
11/01/2007US20070254019 Method for treating brain cancer
11/01/2007US20070254018 Method for site-specific application of topical medicants to aquatic animals
11/01/2007US20070254017 Water soluble film, useful for packaging water treatment products such as sodium dichloroisocyanurate, made of a mixture of an acid stable polyvinyl alcohol; an oxidizable organic material; a chelating agent that is a phosphonic, phosphoric or aminopolycarboxylic acid; and a a free radical scavenger
11/01/2007US20070254016 Biodegradable foam
11/01/2007US20070254015 Sanitizing surfaces
11/01/2007US20070254014 Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
11/01/2007US20070254010 Methylene-containing copolymer of an unsaturated hydrocarbon monomer such as alpha-olefin, diolefin or cyclic olefin and an acrylic or vinyl monomer or having polyether, polylactone or polyester units; crosslinked with a radiation dose of at least 10,000 rads
11/01/2007US20070254009 Antibiotic/bone morphogenic protein formulation and method of treatment
11/01/2007US20070254008 Antibiotic formulation and method of treatment
11/01/2007US20070254006 Medical Devices and Coatings with Non-Leaching Antimicrobial Peptides
11/01/2007US20070253989 Modified Powder and Cosmetic Composition Using the Same
11/01/2007US20070253986 Method For Producing Multiple Emulsions That Are Stable In Storage
11/01/2007US20070253975 Methods for preventing strokes by inducing tolerance to E-selectin
11/01/2007US20070253956 Method for opening tight junctions
11/01/2007US20070253915 Methods for coating dental devices with dry-to-the-touch saliva soluble flavors
11/01/2007US20070253913 Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
11/01/2007US20070253912 Process for the preparation of micronised collagen, and its therapeutic applications
11/01/2007US20070253911 Foamable compositions, kits and methods for hyperhidrosis
11/01/2007US20070253899 Dual Function Polymer Micelles
11/01/2007US20070252295 Amphoteric liposomes containing positive and negative membrane-based or membrane forming charge carriers and having an isoelectric point of between 4 and 8; pH-sensitive liposomes comprise, in particular, cholesterol hemisuccinate
11/01/2007CA2825758A1 Colonic drug delivery formulation
11/01/2007CA2652759A1 Nanoparticles for providing immune responses against infectious agents
11/01/2007CA2650922A1 Pre-mixed, ready-to-use nicardipine compositions
11/01/2007CA2650211A1 Asymmetric membranes for drug delivery devices
11/01/2007CA2650033A1 Compositions and methods useful for treatment of respiratory illness
11/01/2007CA2649900A1 Niosome-hydrogel drug delivery
11/01/2007CA2649895A1 Stable hydroalcoholic oral spray formulations and methods
11/01/2007CA2649630A1 Lipoplex formulations for specific delivery to vascular endothelium
11/01/2007CA2649556A1 Pharmaceutical solution formulations for pressurised metered dose inhalers
11/01/2007CA2649550A1 Polymeric masticatory masses for cosmetic products
11/01/2007CA2649538A1 Buffering agents for biopharmaceutical formulations
11/01/2007CA2649528A1 Therapeutic agent for allergy containing liposome having oligosaccharide on its surface
11/01/2007CA2649514A1 Licorice polyphenol preparation
11/01/2007CA2648939A1 Stable emulsion formulations
11/01/2007CA2648854A1 Fluid container and airless fluid dispensing system
11/01/2007CA2648658A1 Colonic drug delivery formulation
11/01/2007CA2648578A1 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them
11/01/2007CA2648553A1 Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
11/01/2007CA2648495A1 Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
11/01/2007CA2648360A1 Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties
11/01/2007CA2648291A1 Swellable particles for drug delivery
11/01/2007CA2647087A1 Paediatric amino acid solution for parenteral nutrition
11/01/2007CA2646667A1 Methods of treating hot flashes with formulations for transdermal or transmucosal application
11/01/2007CA2646487A1 Bone graft composition
11/01/2007CA2646446A1 Pharmaceutical compositions for promoting wound healing
11/01/2007CA2646206A1 Transdermal delivery system comprising sufentanil and its analogues
10/2007
10/31/2007EP1849830A1 Finely divided composition containing poorly water soluble substance
10/31/2007EP1849487A2 Film-forming compositions and methods
10/31/2007EP1849481A1 Composition for external use
10/31/2007EP1849477A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by ADP-ribosylating exotoxin
10/31/2007EP1849473A1 Chinese traditional medicine composition for treatment of avian influenza, method for preparation, and application thereof
10/31/2007EP1849468A2 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
10/31/2007EP1849466A2 Infusion fluid for dialysis patients
10/31/2007EP1849464A1 Wound dressings
10/31/2007EP1849463A2 Microbial cellulose materials for use in transdermal drug delivery systems, methods of manufacture and use
10/31/2007EP1849462A2 A method of alleviating signs and symptons of Spasticity
10/31/2007EP1849461A1 Process for manufacturing films
10/31/2007EP1849460A2 Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
10/31/2007EP1849459A1 Ezetimibe compositions
10/31/2007EP1849451A1 Sheet structure with at least one coloured face
10/31/2007EP1849434A1 Coating for stents
10/31/2007EP1848794A2 Compositions comprising dehydrated micro-organisms, method for preparing same, and uses thereof
10/31/2007EP1848751A1 Partly neutralised anionic (meth)acrylate copolymer
10/31/2007EP1848722A1 Amorphous taclolimus solid dispersion having an enhanced solubility and pharmaceutical composition comprising same
10/31/2007EP1848541A2 Method and device for ophthalmic administration of active pharmaceutical ingredients
10/31/2007EP1848464A1 Compositions and methods for multimodal imaging
10/31/2007EP1848444A1 Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
10/31/2007EP1848431A1 Liquid formulations for treatment of diseases or conditions
10/31/2007EP1848419A2 Injectable preparations of diclofenic and its pharmaceutically acceptable salts
10/31/2007EP1848412A2 Transdermal systems having control delivery system
10/31/2007EP1848411A2 Copolyhydroxyalkylglutamines which are functionalised with hydrophobic groups and applications thereof, such as in therapeutics
10/31/2007EP1848410A1 Polymer particle delivery compositions and methods of use
10/31/2007EP1848409A1 Propranolol formulations
10/31/2007EP1848408A1 Propranolol formulations
10/31/2007EP1848407A2 Oral pharmaceutical composition
10/31/2007EP1848406A2 Peroral solid dosage form for contraception comprising dienogest and ethinylestradiol
10/31/2007EP1848404A2 Lipid carrier compositions with reduced polydispersity
10/31/2007EP1848403A1 Topical bioadhesive formulations
10/31/2007EP1848402A1 Rasagiline formulations of improved content uniformity
10/31/2007EP1848400A1 Analgesic compositions
10/31/2007EP1848399A1 A compressed chewing gum table
10/31/2007EP1848398A1 Stabilization of viral compositions
10/31/2007EP1848397A1 Composition containing chitosan for sustained drug release
10/31/2007EP1848290A2 Compositions and methods for nutrition supplementation
10/31/2007EP1848271A2 Treatment for topical use alleviating or inhibiting joint pain or muscle pain or musculoskeletal pain in a mammal
10/31/2007EP1848270A2 Transmucosal administration of drug compositions for treating and preventing disorders in animals
10/31/2007EP1771180B1 Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase
10/31/2007EP1680446B1 Compositions comprising melittin-derived peptides and methods for the potentiation of immune responses against target antigens
10/31/2007EP1551493B1 Minimally compliant, volume efficient piston for osmotic drug delivery systems
10/31/2007EP1469941B1 Microparticles and methods for their production
10/31/2007EP1420801B1 Use of fucans in the treatment of adhesions, arthritis and psoriasis
10/31/2007EP1404331B1 Sustained release formulations of oxymorphone
10/31/2007EP1360168A4 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof
10/31/2007EP1294802B1 Polysaccharide based gel
10/31/2007EP1214054B1 Intranasal influenza virus vaccine
10/31/2007EP1140198B1 Use of hyaluronan for the manufacture of a medicament for the enhancement of the efficacy of cytotoxic drugs
10/31/2007EP1078079B1 Methods of forming protein-linked lipidic microparticles, and compositions thereof
10/31/2007DE60125750T2 Pharmazeutische formulierung enthaltend trägerkügelchen mit aufgebrachter schicht aus valaciclovir A pharmaceutical formulation comprising carrier beads made with an applied layer valaciclovir
10/31/2007DE102006020035A1 Herstellung und Verwendung von Poly(hydroxyethylstärke)chitin- und Poly(Carboxymethylstärke)chitin-Verbindungen Preparation and use of poly (hydroxyethyl) chitin and poly (carboxymethyl) chitin-compounds
10/31/2007CN200966773Y Osteoproliferation plaster for reducing pain